As of the end of November, Livzon Pharmaceutical Group (01513.HK) has repurchased a total of 16.1933 million A-shares.

Zhijing Finance APP News, Lianzhuyiyao (01513.HK) announced that as of November 30, 2025, the company has repurchased a total of 16.1933 million A shares of the company through the centralized bidding trading method, accounting for 1.79% of the total share capital of the company. The highest purchase price was RMB 41.99 per share, the lowest price was RMB 33.21 per share, and the total amount of funds used was RMB 600 million (excluding transaction costs). The above repurchase complies with the company's established share repurchase program.